KOSPI · Healthcare · ₩6T
₩464,000-3.63%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 5.9% · as of 26.09.11
Among 5 제약 peers
Quarterly Revenue Growth
“신약 기대는 이어지지만 이제는 실제 판매 성과가 중요해요.”
In the company's words · 2026 2분기 filing